Think we'll see the accountants in and an appeal on the law (as opposed to the facts, which are trial judges domain).
So far facts have been found that CHM contribution was 24%. Dont think that that will be appealed by CHM. I think that they will appeal lack of application of that percentage to the asset and there remains a question as to what constitutes income (ie does it include future earnings.....)
Seems outside of traditional equitable principles for MMX to use CHM money to buy an asset, and for CHM to not get an interest in that asset. It also seems odd that MMX are effectively relying on the fact that they havent made any profit with that asset yet. you dont get the keep the proceeds of naughtiness simply because you havent made any money with the asset yet..........
MMX announcement wording seems curious too. Like their use of the word "invest" to refer to the money that was taken.
- Forums
- ASX - By Stock
- CHM
- ann out "chameleon wins murchison litigation"
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

ann out "chameleon wins murchison litigation", page-52
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18587873 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.004 |
40 | 26959271 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18587873 | 22 |
0.006 | 13384684 | 15 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2390797 | 5 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online